Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency

Environmental Health Perspectives, June, 2005 by Jonathan J. Carmouche, J. Edward Puzas, Xinping Zhang, Prarop Tiyapatanaputi, Deborah A. Cory-Slechta, Robert Gelein, Michael Zuscik, Randy N. Rosier, Brendan F. Boyce, Regis J. O'Keefe, Edward M. Schwarz

Long GJ, Rosen JF, Pounds JG. 1990. Cellular lead toxicity and metabolism in primary and clonal osteoblastic bone cells. Toxicol Appl Pharmacol 102:346-361.

Markowitz ME, Gundberg CM, Rosen JF. 1988. Sequential osteocalcin sampling as a biochemical marker of the success of treatment in moderately lead (Pb) poisoned children [Abstract]. Pediatr Res 23:393.

Miyahara T, Komiyama H, Miyanisbi A, Matsumoto M, Xue-Ya W, Takata M, et al. 1994. Effects of lead on osteoclast-like cell formation in mouse bone marrow cell cultures. Calcif Tissue Int 54:165-169.

Moss M, Lanphear B, Auigner P. 1999. Association of dental caries and blood lead levels. JAMA 281:2294-2298.

Parsons PJ. 1993. A rapid Zeeman graphite furnace atomic absorption spectrometric method for the determination of lead in blood. Spectrochim Acta 48B:925-939.

Pearl M, Boxt LM. 1980. Radiographic findings in congenital lead poisoning. Radiology 136:83-84.

Pirkle JL, Kaufman RB, Brody DJ, Hickman T, Bunter EW, Paschal DC. 1998. Exposure of the U.S. population to lead, 1991-1994. Environ Health Perspect 106:745-750.

Pounds JG, Long GJ, Rosen JF. 1991. Cellular and molecular toxicity of lead in bone. Environ Health Perspect 91:17-32.

Puzas JE, Campbell JR, O'Keefe RJ, Rosier RN. 2004. Nutrition and Bone Health. Totowa, NJ:Humana Press,

Puzas JE, Sickel MJ, Felter ME. 1992. Osteoblasts and chondrocytes are important target cells for the toxic effects of lead. Neurotoxicology 13:783-788.

Schanne FA, Dowd TL, Gupta RK, Rosen JF. 1989. Lead increases free Ca2 concentration in cultured osteoblastic bone cells: simultaneous detection of intracellular free Pb2 by 19F NMR. Proc Natl Acad Sci USA 86:5133-5135.

Schanne FA, Dowd TL, Gupta RK, Rosen JF. 1990. Effect of lead on parathyroid hormone-induced responses in rat osteoblastic esteosarcoma cells (ROS 17/2.8) using 19F-NMR. Biochim Biophys Acta 1054:250-255.

Schwartz J, Angle C, Pitcher H. 1986. Relationship between childhood blood lead levels and stature. Pediatrics 77:281-288.

Schwarz EM, Krimpenfort P, Berns A, Verma IM. 1997. Immunological defects in mice with e targeted disruption in Bcl-3. Genes Dev 11:187-197.

Shukla R, Bornschein RL, Dietrich KN, Buncher CR, Berger OG, Hammond PB, et al. 1989. Effects of fetal and infant lead exposure on growth in stature. Pediatrics 84:604-612.

Silbergeld EK, Sauk J, Somerman M, Todd A, McNeill F, Fowler B, et al. 1993. Lead in bone: storage site, exposure source, and target organ. Neurotoxicology 14:225-236.

Silbergeld EK, Schwartz J, Mahaffey K. 1988. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 47:79-94.

Wittmers LE Jr, Aufderheide AC, Wallgren J, Rapp G Jr, Alich A. 1988. Lead in bone. IV. Distribution of lead in the human skeleton. Arch Environ Health 43:381-391.

Yin J, Selander K, Chirgwin J, Dallas M, Grubbs B, Wieser R, et al. 1999. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197-206.

Zhang X, Morham SG, Langenback R, Young DA, Xing L, Boyce BF, et al. 2001. Evidence for a direct role of COX-2 in implant wear debris induced osteolysis. J Bone Miner Res 16:660-670.